tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Parry, 3 are a HOLD (42.86%), 1 are a SELL (14.29%), 3 are a BUY (42.86%).
Analyst Graham Parry, currently employed at BAML, carries an average stock price target met ratio of 66.67% that have a potential upside of 58.62% achieved within 2267 days.
Graham Parry’s has documented 12 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 11-Sep-2023.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 3/28/2023. The price target of $113.35 was fulfilled within 512 days with a profit of $33.33 (41.65%) receiving and performance score of 0.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$41
$-2.54 (-5.83%)
10 months 15 days ago
(01-Dec-2024)
1/1 (100%)
$7.82 (23.57%)
182
Hold
$53
11 months 5 days ago
(11-Nov-2024)
3/5 (60%)
$16.8 (46.41%)
323
Buy
1 years 2 months 16 days ago
(31-Jul-2024)
0/13 (0%)
$-16.49 (-43.22%)
Buy
$45
$1.46 (3.35%)
$47
1 years 3 months 1 days ago
(15-Jul-2024)
2/3 (66.67%)
$8.15 (22.12%)
976
Buy
$19.52
1 years 8 months 4 days ago
(12-Feb-2024)
0/3 (0%)
$-12.79 (-39.59%)
What Year was the first public recommendation made by Graham Parry?
